Atomica AI brings treatment-planning software for dentists to LEAP

Atomica AI, a dental technology company, is at LEAP 2026 in Riyadh showing AI-assisted treatment-planning software that dentists use to design implant procedures and, more recently, a wider set of restorative work, connecting scanning, planning, surgical guide design and lab handoff in one workflow. The software's original focus is guided implant surgery: a dentist takes a 3D scan of a patient's mouth, and Atomica's software helps plan implant placement in that model before any drilling happens, then generates a surgical guide — a physical template that constrains where and at what angle the dentist can drill — manufactured in-office or through a lab. Atomica says it has since expanded the same AI capabilities to a broader range of restorative treatments, including crowns, bridges, inlays, onlays, veneers and splints, extending the planning workflow beyond implants into routine restorative dentistry. The company says its underlying model has been trained on more than a million cases, a figure that describes the training data set rather than a count of patients treated using the software in practice, and that distinction matters for anyone assessing the claim. None of this is a claim of clinical validation, and none should be read as one. Software that helps a dentist plan a procedure and produce a guide is a decision-support and manufacturing tool; it is not a diagnosis, and Atomica's own public materials describe treatment planning and guide fabrication rather than outcomes data, peer-reviewed trial results, or a regulatory clearance for the software in any specific market, including Saudi Arabia. Digital treatment planning is already established practice in implant dentistry — 3D simulation before surgery is a known technique in the field, and Atomica has previously partnered with implant systems maker 3Sixty to bring the software to market — and what a vendor like Atomica is selling is a faster, AI-assisted route to a guide a dentist would otherwise design by hand or order from a specialist lab. That is a workflow-efficiency claim, not a claim that the resulting treatment is safer or more effective than one planned conventionally. The Saudi market Atomica is pitching at LEAP has its own momentum in health-adjacent AI this week: LIVE4WELL used the show to showcase an AI-driven preventive health platform , and the Tech Arena has featured AI-powered prosthetics and brain-computer interfaces alongside it, part of a broader pattern of medical and dental AI vendors treating LEAP as a launchpad into Gulf clinics and hospital groups rather than only enterprise and government buyers. What has not been disclosed is any Saudi Arabia-specific detail: no named dental group, no distributor, no filing with the Saudi Food and Drug Authority, and no local pricing or rollout timeline. A dental practice evaluating the software would still need to see how it performs on its own cases, not the training-set size the company quotes. TechScoop is reporting from LEAP 2026 in Riyadh.